Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- Check6 days agoChange DetectedMelanoma topic tag and the related MedlinePlus Genetics topics have been removed from the page. This reduces disease-specific context and topic mapping for search and classification.SummaryDifference0.1%

- Check13 days agoChange DetectedMelanoma-related topics, related topic links, and a new Revision: v3.4.2 were added. An older revision note and a funding-status notice were removed.SummaryDifference0.5%

- Check20 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check27 days agoChange DetectedMinor UI and metadata changes: the glossary toggle is shown, the QC criteria label wording was adjusted, and the revision tag was updated from v3.3.4 to v3.4.0.SummaryDifference0.4%

- Check42 days agoChange DetectedAdded Melanoma and the related topic MedlinePlus Genetics, and updated the page revision to v3.3.4 (replacing v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page's related topics section was updated to remove 'Melanoma' and MedlinePlus Genetics; no core content or user-facing functionality was changed. To avoid being alerted by small changes, set an alert condition below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.